Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
209
datasets available to search
ShareScore release 0.9.0
Dataset results
209 results for “Intrahepatic cholangiocarcinoma”
Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02512692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT03251443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
ClinicalTrials.gov study NCT06728410. IPD Sharing: NO. Countries: 1. Publications: 0.
Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06567600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06721286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT04708067. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT05251662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT04299581. IPD Sharing: NO. Countries: 1. Publications: 0.
Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06058663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT05535647. IPD Sharing: NO. Countries: 1. Publications: 0.
Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)
ClinicalTrials.gov study NCT06860477. IPD Sharing: NO. Countries: 1. Publications: 0.
Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06956716. IPD Sharing: NO. Countries: 1. Publications: 0.
Streamlining Radioembolization for Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT07043348. IPD Sharing: NO. Countries: 1. Publications: 0.
TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection
ClinicalTrials.gov study NCT02588755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway
ClinicalTrials.gov study NCT01917370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT05678270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
ClinicalTrials.gov study NCT07328919. IPD Sharing: NO. Countries: 1. Publications: 0.
HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT05400902. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT05967182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06192784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.